Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.020 | None | < 0.001 | 2 | 1 | 2002 | 2002 | ||||||||
|
ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 0.551 | 0.885 | 2.8E-15 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
doublecortin domain containing 2 | 0.546 | 0.769 | 5.7E-10 |
|
disease | 0.110 | None | < 0.001 | 1 | 1 | 2020 | 2020 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
heat shock protein family A (Hsp70) member 9 | 0.502 | 0.885 | 0.97 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
complement C1q like 1 | 0.612 | 0.654 | 5.6E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
BTB domain containing 8 | 0.547 | 0.692 | 6.1E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
solute carrier family 9 member A5 | 0.780 | 0.346 | 1.8E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2000 | 2000 | ||||||||
|
solute carrier family 9 member A1 | 0.550 | 0.731 | 0.79 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2000 | 2000 | ||||||||
|
inhibitor of DNA binding 2 | 0.572 | 0.731 | 0.67 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
contactin 3 | 0.612 | 0.654 | 2.0E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
chorionic somatomammotropin hormone 1 | 0.566 | 0.808 | 2.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
zinc finger C4H2-type containing | 0.561 | 0.731 | 0.91 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
apolipoprotein L4 | 0.839 | 0.231 | 1.1E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
molybdenum cofactor sulfurase | 0.617 | 0.654 | 1.6E-19 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
sperm mitochondria associated cysteine rich protein | 0.621 | 0.692 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | |||||||||
|
chorionic somatomammotropin hormone 2 | 0.566 | 0.808 | 1.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
hepatitis A virus cellular receptor 1 | 0.489 | 0.885 | 8.5E-07 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2015 | 2019 | ||||||||
|
alanine--glyoxylate and serine--pyruvate aminotransferase | 0.593 | 0.731 | 1.2E-07 |
|
disease | 0.120 | None | 0.500 | 2 | 2 | 2019 | 2019 | ||||||||
|
ephrin B2 | 0.561 | 0.692 | 0.99 |
|
disease | 0.020 | None | 0.500 | 2 | 2 | 2008 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2003 | ||||||||
|
solute carrier family 9 member A3 | 0.612 | 0.615 | 0.98 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2000 | 2019 |